These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 21957126

  • 1. Residues in domain III of the dengue virus envelope glycoprotein involved in cell-surface glycosaminoglycan binding.
    Watterson D, Kobe B, Young PR.
    J Gen Virol; 2012 Jan; 93(Pt 1):72-82. PubMed ID: 21957126
    [Abstract] [Full Text] [Related]

  • 2. Characterization of the interaction of domain III of the envelope protein of dengue virus with putative receptors from CHO cells.
    Huerta V, Chinea G, Fleitas N, Sarría M, Sánchez J, Toledo P, Padrón G.
    Virus Res; 2008 Nov; 137(2):225-34. PubMed ID: 18723056
    [Abstract] [Full Text] [Related]

  • 3. [Secreted expression of dengue virus type 2 envelope glycoprotein in eukaryotic cells].
    Zhang S, Gu W, Li C, Miao F, Lu P, Qu J, Wei Y, Zhang QF, Liu QZ, Li JD, Liang MF, Li DX.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Apr; 25(2):85-8. PubMed ID: 21863624
    [Abstract] [Full Text] [Related]

  • 4. A novel mosquito ubiquitin targets viral envelope protein for degradation and reduces virion production during dengue virus infection.
    Troupin A, Londono-Renteria B, Conway MJ, Cloherty E, Jameson S, Higgs S, Vanlandingham DL, Fikrig E, Colpitts TM.
    Biochim Biophys Acta; 2016 Sep; 1860(9):1898-909. PubMed ID: 27241849
    [Abstract] [Full Text] [Related]

  • 5. Basic chemokine-derived glycosaminoglycan binding peptides exert antiviral properties against dengue virus serotype 2, herpes simplex virus-1 and respiratory syncytial virus.
    Vanheule V, Vervaeke P, Mortier A, Noppen S, Gouwy M, Snoeck R, Andrei G, Van Damme J, Liekens S, Proost P.
    Biochem Pharmacol; 2016 Jan 15; 100():73-85. PubMed ID: 26551597
    [Abstract] [Full Text] [Related]

  • 6. Sulfated Escherichia coli K5 polysaccharide derivatives inhibit dengue virus infection of human microvascular endothelial cells by interacting with the viral envelope protein E domain III.
    Vervaeke P, Alen M, Noppen S, Schols D, Oreste P, Liekens S.
    PLoS One; 2013 Jan 15; 8(8):e74035. PubMed ID: 24015314
    [Abstract] [Full Text] [Related]

  • 7. Probing the interaction of dengue virus envelope protein with heparin: assessment of glycosaminoglycan-derived inhibitors.
    Marks RM, Lu H, Sundaresan R, Toida T, Suzuki A, Imanari T, Hernáiz MJ, Linhardt RJ.
    J Med Chem; 2001 Jun 21; 44(13):2178-87. PubMed ID: 11405655
    [Abstract] [Full Text] [Related]

  • 8. Suppressive effect of dengue virus envelope protein domain III on megakaryopoiesis.
    Lin GL, Chang HH, Lien TS, Chen PK, Chan H, Su MT, Liao CY, Sun DS.
    Virulence; 2017 Nov 17; 8(8):1719-1731. PubMed ID: 28622093
    [Abstract] [Full Text] [Related]

  • 9. Dengue virus type 2 envelope protein displayed as recombinant phage attachment protein reveals potential cell binding sites.
    Abd-Jamil J, Cheah CY, AbuBakar S.
    Protein Eng Des Sel; 2008 Oct 17; 21(10):605-11. PubMed ID: 18669522
    [Abstract] [Full Text] [Related]

  • 10. Identification of sequence motifs involved in Dengue virus-host interactions.
    Asnet Mary J, Paramasivan R, Shenbagarathai R.
    J Biomol Struct Dyn; 2016 Oct 17; 34(3):676-87. PubMed ID: 25905427
    [Abstract] [Full Text] [Related]

  • 11. Human monoclonal single-chain antibodies specific to dengue virus envelope protein.
    Saokaew N, Poungpair O, Panya A, Tarasuk M, Sawasdee N, Limjindaporn T, Chaicumpa W, Yenchitsomanus P.
    Lett Appl Microbiol; 2014 Mar 17; 58(3):270-7. PubMed ID: 24266517
    [Abstract] [Full Text] [Related]

  • 12. A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection.
    Panya A, Sawasdee N, Junking M, Srisawat C, Choowongkomon K, Yenchitsomanus PT.
    Chem Biol Drug Des; 2015 Nov 17; 86(5):1093-104. PubMed ID: 25891143
    [Abstract] [Full Text] [Related]

  • 13. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate.
    Chen Y, Maguire T, Hileman RE, Fromm JR, Esko JD, Linhardt RJ, Marks RM.
    Nat Med; 1997 Aug 17; 3(8):866-71. PubMed ID: 9256277
    [Abstract] [Full Text] [Related]

  • 14. The stem region of premembrane protein plays an important role in the virus surface protein rearrangement during dengue maturation.
    Zhang Q, Hunke C, Yau YH, Seow V, Lee S, Tanner LB, Guan XL, Wenk MR, Fibriansah G, Chew PL, Kukkaro P, Biukovic G, Shi PY, Shochat SG, Grüber G, Lok SM.
    J Biol Chem; 2012 Nov 23; 287(48):40525-34. PubMed ID: 23035113
    [Abstract] [Full Text] [Related]

  • 15. Amino acid changes within the E protein hinge region that affect dengue virus type 2 infectivity and fusion.
    Butrapet S, Childers T, Moss KJ, Erb SM, Luy BE, Calvert AE, Blair CD, Roehrig JT, Huang CY.
    Virology; 2011 Apr 25; 413(1):118-27. PubMed ID: 21353281
    [Abstract] [Full Text] [Related]

  • 16. [Mapping of the B Cell Neutralizing Epitopes on ED III of Envelope Protein from Dengue Virus].
    Lin Y, Wen K, Guo Y, Qiu L, Pan Y, Yu L, Di B, Chen Y.
    Bing Du Xue Bao; 2015 Nov 25; 31(6):665-73. PubMed ID: 26951013
    [Abstract] [Full Text] [Related]

  • 17. Prediction of the post-translational modification sites on dengue virus E protein and deciphering their role in pathogenesis.
    Ruhul Amin M, Mahbub AH, Sikder AR, Karim MM.
    Int J Bioinform Res Appl; 2010 Nov 25; 6(5):508-21. PubMed ID: 21224207
    [Abstract] [Full Text] [Related]

  • 18. Interaction and inhibition of dengue envelope glycoprotein with mammalian receptor DC-sign, an in-silico approach.
    Shah M, Wadood A, Rahman Z, Husnain T.
    PLoS One; 2013 Nov 25; 8(3):e59211. PubMed ID: 23527139
    [Abstract] [Full Text] [Related]

  • 19. Bacterially expressed and refolded envelope protein (domain III) of dengue virus type-4 binds heparan sulfate.
    Pattnaik P, Babu JP, Verma SK, Tak V, Rao PV.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb 01; 846(1-2):184-94. PubMed ID: 17011249
    [Abstract] [Full Text] [Related]

  • 20. Crucial role of the N-glycans on the viral E-envelope glycoprotein in DC-SIGN-mediated dengue virus infection.
    Alen MM, Dallmeier K, Balzarini J, Neyts J, Schols D.
    Antiviral Res; 2012 Dec 01; 96(3):280-7. PubMed ID: 23124109
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.